Tricuspid Valve Replacement after Extensive Endocarditis Using Cormatrix® Extracellular Matrix
Received Date: Jan 29, 2018 / Accepted Date: Feb 22, 2018 / Published Date: Feb 28, 2018
Tricuspid valve replace in patients with active endocarditis can be a challenging decision in surgical options. In this experience, we replaced the tricuspid valve using a handmade single tube of CorMatrix Extracellular Matrix (ECM) (CorMatrix Cardiovascular Inc, Roswell, Ga). Its showed to be safe and useful in a young patient with extensive valve destruction and early follow-up showed symptomatic resolution and valve normal function.
Keywords: Endocarditis; Tricuspid valve insufficiency; Heart valve disease
Citation: Lucero F, Quiroz M, Baeza C, Oyonarte M (2018) Tricuspid Valve Replacement after Extensive Endocarditis Using Cormatrix® Extracellular Matrix. J Clin Case Rep 8: 1085. Doi: 10.4172/2165-7920.10001085
Copyright: ©2018 Lucero F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 1618
- [From(publication date): 0-2018 - Feb 19, 2020]
- Breakdown by view type
- HTML page views: 1560
- PDF downloads: 58